• Bio Protech held an investor relations briefing on Oct. 6, 2026, at Korea Exchange Market Square in Seoul.
• Session ran 13:30–15:10 local time.
• Presentation covered business overview, operating status, forward plans, followed by Q&A with analysts, institutional investors, venture capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Protech Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006600400), on October 06, 2026, and is solely responsible for the information contained therein.